In a study published in September 2021, SDC2 methylation, as well as ADHFE1 and PPP2R5C methylation, have been revealed as good CRC biomarkers, confirming the accuracy of SDC2 methylation as a CRC indicator [64]. The gene discussed is ADHFE1; the disease is colorectal carcinoma.